SABRINA LIU: Open Payments
NPI 1841766185 · ALHAMBRA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,011 in 42 payments from 14 companies in 2025. Trend: 2023 $410 · 2024 $389 · 2025 $1,011
Food & beverage: $1,011
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 8 | $222 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $189 |
| GlaxoSmithKline, LLC. | 4 | $95 |
| Verona Pharma, Inc. | 3 | $89 |
| Novo Nordisk Inc | 3 | $70 |
| Ardelyx, Inc. | 2 | $64 |
| Kowa Pharmaceuticals America, Inc. | 3 | $61 |
| Corcept Therapeutics | 2 | $49 |
| Sumitomo Pharma America, Inc. | 2 | $45 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $35 |
Products named: COSENTYX, Kerendia, Ohtuvayre, IBSRELA, SHINGRIX, ZORYVE, Korlym, GEMTESA.
Industry payments across CA — which companies pay providers there.
